The global pharmacogenomics market is rapidly expanding as precision medicine reshapes modern healthcare, enabling tailored drug therapies based on an individual’s genetic profile. With a market value of approximately USD 9.62 billion in 2024, the industry is projected to reach nearly USD 21.87 billion by 2032, advancing at a strong CAGR...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek